Linda Liau's lecture "The Promise of Immunotherapy for Treatment of Glioblastoma" on Wednesday, October 26, 2022 Stuart Rowe lecture at the University of Pittsburgh.
flipper44, there were actually 2 different slides and presentations. The first slide was from Dr. Liau’s presentation in February 2022 at the Weill Cornell Medicine (WCM) Brain and Spine Center.
You can hear the part about the DCVax-L + poly-ICLC combination starting at around the 20:25 minute mark, through the 23:20 minute mark. You can see the graph from Allen Turner’s tweet at the 22:35 minute mark. Here is the link to the presentation below:
The 2nd graph is from Dr. Liau’s presentation on October 26, 2022 at the University of Pittsburgh.
On the first graph from February 2022, the OS for the DCVax-L + poly-ICLC was approaching 100 months (8.33 years), and the PFS was over 90 months (7.5 years).
On the 2nd graph from October 2022 (8 months later), OS for the DCVax-L + poly-ICLC was approaching 120 months (10 years), and PFS was over 100 months (8.33 years.).
News 
Market Data 
Discover 
